| abstract |
IT REFERS TO A PHARMACEUTICAL COMPOSITION THAT INCLUDES: A) A BIODEGRADABLE POLYMER AS LINEAR OR BRANCHED POLY-LACTIC-CO-GLYCOLIDE; B) A POLYETHYLENE GLYCOL WHOSE MOLECULAR WEIGHT IS LESS THAN 600 DALTONS SELECTED FROM PEG 200, PEG 300, PEG 400, AMONG OTHERS; C) A PHARMACEUTICALLY PREFERRED AGENT AN ANALOGUE OF SOMATOSTATIN; D) LESS THAN 0.5% APPROX. OF AN ORGANIC SOLVENT SUCH AS N-METHYL-2-PYRROLIDONE, 2-PYRROLIDONE, ETHANOL, AMONG OTHERS; E) AN ADDITIVE SUCH AS METHANOL, PROPYLENE GLYCOL, LACTIC ACID, AMONG OTHERS. ALSO REFERRED TO A PREPARATION PROCEDURE. SUCH COMPOSITION, FOR PARENTERAL ADMINISTRATION, MAY BE STORED FOR A LONG PERIOD OF TIME WITHOUT PRECIPITATION AND ARE USEFUL IN THE TREATMENT OF THE KNOWN INDICATIONS OF THE ACTIVE AGENT |